FDA 21 CFR
CFR Title 21 AI consultation best practices
Real-time interpretation of CFR Title 21 regulations through advanced language models.
Overview
The AI consultation system helps compliance officers quickly understand regulatory requirements and their practical implications.
The AI is a supplementary tool — use it alongside human expertise and official FDA guidance. Always verify AI interpretations against official sources.
Key features
Regulatory interpretation
- Plain-language explanations of complex regulations
- Context-aware interpretations
- Cross-reference identification
- Historical context and precedents
Query capabilities
- Natural-language question processing
- Specific regulation lookups
- Related requirement suggestions
- Compliance scenario analysis
Documentation support
- Citation generation
- Requirement summaries
- Compliance checklist creation
- Export for documentation
Effective query techniques
- Be specific about the regulation section
- Provide context about your use case
- Ask for practical examples when needed
- Request clarification on technical terms
- Verify cross-references and related requirements
- Document important interpretations for later
Understanding AI responses
Response components
- Regulatory interpretation
- Relevant citations
- Related requirements
- Practical implications
Verification steps
- Cross-reference with official CFR documentation
- Review cited regulations in context
- Consult subject-matter experts
- Document the verification process
Best practices
- Always verify interpretations against official sources
- Use specific, well-structured queries
- Document both questions and answers
- Maintain context in follow-up questions
- Regularly review saved interpretations
- Share important insights with your team
- Track regulation updates that affect prior interpretations
Limitations & considerations
- AI interpretations are supplementary guidance only
- Recent regulatory changes may not be reflected immediately
- Complex scenarios may require human expert consultation
- Always prioritize official FDA guidance
- Document any discrepancies found